Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 18.60
-0.20 (-1.06%)
At close: Feb 11, 2026
TPEX:4431 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,911 | 1,759 | 1,293 | 1,472 | 291.62 | 1,024 | |
Revenue Growth (YoY) | 30.51% | 36.02% | -12.14% | 404.61% | -71.51% | 156.92% |
Cost of Revenue | 1,684 | 1,537 | 1,101 | 1,232 | 251.48 | 395.12 |
Gross Profit | 226.71 | 221.55 | 192.35 | 239.4 | 40.14 | 628.52 |
Selling, General & Admin | 323.31 | 337.77 | 294.25 | 310.74 | 53.65 | 188.66 |
Research & Development | 3.49 | 2.86 | 12.3 | 16.4 | 1.98 | - |
Other Operating Expenses | -42.25 | -42.21 | -43.65 | -40.87 | -0.01 | -0.15 |
Operating Expenses | 293.11 | 299.09 | 264.17 | 286.15 | 55.6 | 190.27 |
Operating Income | -66.39 | -77.54 | -71.83 | -46.74 | -15.46 | 438.25 |
Interest Expense | -5.86 | -6.13 | -6.22 | -5.21 | -1.58 | -1.34 |
Interest & Investment Income | 3.41 | 2.89 | 2.3 | 1.15 | 0.67 | 0.55 |
Earnings From Equity Investments | 0.75 | -0.26 | 0.94 | 1.66 | -0.86 | -0.4 |
Currency Exchange Gain (Loss) | -2.3 | 2.6 | 0.76 | 10.24 | -4.05 | -0.27 |
Other Non Operating Income (Expenses) | 24.43 | 18.26 | 20.05 | 20.9 | 0.15 | -2.18 |
EBT Excluding Unusual Items | -45.96 | -60.18 | -54 | -18.01 | -21.13 | 434.6 |
Gain (Loss) on Sale of Investments | - | - | - | -1.06 | 33.34 | 6.41 |
Gain (Loss) on Sale of Assets | -0.4 | 17.51 | -4.1 | 8.68 | -0.16 | 0.15 |
Asset Writedown | -41.65 | -41.65 | 0.92 | -51.47 | -25.65 | - |
Pretax Income | -88.01 | -84.32 | -57.18 | -61.86 | -13.6 | 441.16 |
Income Tax Expense | 1.79 | 0.51 | 1.11 | 7.1 | 0.45 | 89.57 |
Earnings From Continuing Operations | -89.79 | -84.83 | -58.29 | -68.96 | -14.05 | 351.59 |
Minority Interest in Earnings | 6.49 | 2.46 | 2.07 | -22.94 | 0.04 | 0.68 |
Net Income | -83.3 | -82.38 | -56.22 | -91.9 | -14.01 | 352.27 |
Net Income to Common | -83.3 | -82.38 | -56.22 | -91.9 | -14.01 | 352.27 |
Net Income Growth | - | - | - | - | - | 3680.58% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 32 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 33 |
Shares Change (YoY) | - | - | - | 0.00% | 11.05% | 3.86% |
EPS (Basic) | -2.28 | -2.25 | -1.54 | -2.52 | -0.38 | 10.97 |
EPS (Diluted) | -2.28 | -2.25 | -1.54 | -2.52 | -0.38 | 10.71 |
EPS Growth | - | - | - | - | - | 3625.23% |
Free Cash Flow | -4.02 | 22.75 | -26.03 | 36.98 | -16.46 | 252.76 |
Free Cash Flow Per Share | -0.11 | 0.62 | -0.71 | 1.01 | -0.45 | 7.68 |
Dividend Per Share | - | - | - | - | - | 3.333 |
Dividend Growth | - | - | - | - | - | 2450.34% |
Gross Margin | 11.86% | 12.60% | 14.88% | 16.27% | 13.76% | 61.40% |
Operating Margin | -3.48% | -4.41% | -5.56% | -3.18% | -5.30% | 42.81% |
Profit Margin | -4.36% | -4.68% | -4.35% | -6.25% | -4.80% | 34.41% |
Free Cash Flow Margin | -0.21% | 1.29% | -2.01% | 2.51% | -5.64% | 24.69% |
EBITDA | -0.54 | -2.48 | 4.65 | 36.75 | 23.65 | 460.78 |
EBITDA Margin | -0.03% | -0.14% | 0.36% | 2.50% | 8.11% | 45.01% |
D&A For EBITDA | 65.86 | 75.07 | 76.48 | 83.49 | 39.11 | 22.53 |
EBIT | -66.39 | -77.54 | -71.83 | -46.74 | -15.46 | 438.25 |
EBIT Margin | -3.47% | -4.41% | -5.56% | -3.18% | -5.30% | 42.81% |
Effective Tax Rate | - | - | - | - | - | 20.30% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.